Collagen is the most abundant protein in the body, forming the structural foundation of skin, cartilage, tendons, ligaments, and bone. Vitamin C contributes to normal collagen formation for the normal function of bones, cartilage, skin, and gums — an EFSA-approved claim. Supplemental collagen peptides have been studied in human trials for joint comfort and skin quality, with a growing body of randomised controlled trial data.
Key Takeaways
- Collagen accounts for roughly one-third of total body protein and is the primary structural component of skin, cartilage, tendons, and bone.1
- Vitamin C contributes to normal collagen formation for bones, cartilage, skin, and gums — an approved EFSA health claim.
- A 2024 updated meta-analysis of 11 randomised controlled trials (870 participants) reported that oral collagen supplementation was associated with improvements in joint function and comfort scores compared to placebo.2
- A 2023 meta-analysis of 26 RCTs (1,721 participants) found that hydrolysed collagen supplementation was associated with significantly improved skin hydration and elasticity versus placebo, with effects observed after 8 or more weeks.3
- The evidence base for collagen supplementation, while growing, shows high heterogeneity across trials and risk of industry funding bias; findings should be interpreted with appropriate caution.4
- Biotin and zinc each carry EFSA-approved claims for contribution to maintenance of normal skin and hair — supporting nutrients to consider alongside collagen and vitamin C.
- Third-party tested supplements with transparent labelling and verified ingredient forms offer the clearest foundation for any connective tissue support routine.
What Is Collagen and Why Does It Decline with Age?
Collagen is a structural protein — more accurately, a family of over 28 distinct proteins — that provides tensile strength and structural integrity to connective tissue throughout the body. It forms the primary component of skin's dermis, the matrix of cartilage in joints, the scaffold of tendons and ligaments, and a key element of the bone organic matrix. Types I, II, and III account for the vast majority of total body collagen, with Type I found in skin and bone, Type II concentrated in cartilage, and Type III present alongside Type I in skin, blood vessels, and organs.1
Collagen is synthesised primarily by specialised cells: fibroblasts in skin and connective tissue, and chondrocytes in cartilage. The synthesis process is complex, involving post-translational modifications in which proline and lysine residues are hydroxylated by enzymes that require vitamin C as an essential cofactor. These hydroxylations are critical to the formation of the characteristic triple-helix structure that gives collagen its mechanical strength. Without adequate vitamin C, this hydroxylation process is impaired — the clinical consequence of severe vitamin C deficiency (scurvy) is a direct illustration of collagen's dependence on this nutrient.
From approximately the mid-twenties onward, collagen synthesis slows and structural degradation by matrix metalloproteinases gradually accumulates. Skin collagen density is estimated to decline by approximately 1% per year in adults, with accelerated loss observed in post-menopausal women due to reduced oestrogen, which normally supports collagen gene expression. In cartilage, the balance between collagen synthesis and breakdown shifts progressively with age, contributing to the gradual changes in joint tissue observed across the population. This biological context has motivated scientific interest in both optimising the nutrients required for endogenous collagen synthesis — particularly vitamin C — and investigating whether oral supplemental collagen peptides can contribute to connective tissue support.
Vitamin C and Collagen Formation: The EFSA-Approved Connection
Vitamin C (ascorbic acid) occupies a uniquely well-established position in collagen biology. It functions as an essential cofactor for two hydroxylase enzymes — prolyl hydroxylase and lysyl hydroxylase — that catalyse the addition of hydroxyl groups to proline and lysine residues within newly synthesised procollagen chains.1 These hydroxylated residues are required for the procollagen chains to fold correctly into the stable triple-helix configuration. Beyond its cofactor role, vitamin C also directly stimulates collagen gene expression and procollagen secretion at a transcriptional or translational level, an effect that appears to be independent of its hydroxylation function.5
The European Food Safety Authority has approved the following health claim for vitamin C: it contributes to normal collagen formation for the normal function of bones, cartilage, skin, and gums. This claim reflects the robust mechanistic and nutritional evidence linking vitamin C status to collagen synthesis capacity. At an adequate intake level, vitamin C ensures the enzymatic machinery required for collagen formation operates normally. At deficient levels, the characteristic signs of scurvy — poor wound healing, skin fragility, joint discomfort, and gum vulnerability — all trace back to impaired collagen synthesis.
Most adults in developed countries achieve adequate vitamin C intake through diet. However, certain groups may have increased requirements or sub-optimal status: older adults, smokers (tobacco increases ascorbate utilisation), individuals with poor dietary variety, and people with high physiological demands. From a supplementation perspective, vitamin C is well-tolerated, water-soluble, and inexpensive. Typical dietary and supplementation ranges of 100–500 mg daily are generally considered sufficient to support normal collagen synthesis, with the body maintaining saturation at relatively modest intakes.
Human Evidence for Collagen Peptide Supplementation: Joints
Collagen peptides — also called hydrolysed collagen — are produced by breaking down native collagen protein into short-chain peptides through enzymatic hydrolysis. These smaller fragments (typically 2–10 kDa) are more readily absorbed from the gastrointestinal tract than intact collagen. Human pharmacokinetic studies have detected collagen-derived dipeptides, particularly prolyl-hydroxyproline (Pro-Hyp) and hydroxyprolyl-glycine, in the bloodstream following oral ingestion, and animal studies indicate accumulation in cartilage tissue — though the clinical relevance of this in humans is still being characterised.
The clinical trial evidence for joint outcomes has grown substantially over the past decade. A 2024 updated systematic review and meta-analysis by Simental-Mendía and colleagues analysed 11 randomised controlled trials involving 870 participants with knee osteoarthritis. The pooled analysis reported significant improvement in both pain scores and joint function scores in the collagen supplementation group compared to placebo, with results favouring collagen supplementation.2 The authors noted high heterogeneity across studies and judged the included trials to have moderate risk of bias, reflecting the limitations common to nutritional intervention research in this area.
A separate large-scale meta-analysis examining collagen derivatives for osteoarthritis, which included 35 RCTs and 3,165 participants, reported small-to-moderate effects on pain relief and functional improvement compared to placebo control, with the certainty of evidence rated as moderate for the functional outcomes.6 The dosages studied across trials varied from approximately 5 g to 15 g per day, with study durations typically ranging from 12 weeks to 6 months.
It is important to maintain proportionate interpretation of these findings. The trials are heterogeneous in their populations, dosing regimens, and collagen types (Types I, II, and III hydrolysates have each been studied). Many trials have moderate risk of bias, particularly related to industry sponsorship. The evidence suggests a plausible and potentially meaningful signal for joint comfort in adults with established joint changes, but collagen supplements should be understood as a supportive nutritional intervention, not a therapeutic replacement for established joint management approaches.
Human Evidence for Collagen Peptide Supplementation: Skin
The evidence base for collagen peptides and skin outcomes is more extensive than for joint outcomes. A 2023 systematic review and meta-analysis by Pu and colleagues — the largest published at the time — pooled data from 26 randomised controlled trials involving 1,721 participants. The analysis reported that hydrolysed collagen supplementation was associated with significantly improved skin hydration and skin elasticity compared to placebo (Z = 4.94, p < 0.00001 for hydration; Z = 4.49, p < 0.00001 for elasticity). Beneficial effects were consistent after eight or more weeks of supplementation.3
However, the picture is complicated by a 2025 meta-analysis that specifically examined the influence of funding source on trial outcomes. This analysis of 23 RCTs (1,474 participants) found that when examining only studies without pharmaceutical industry funding, and only high-quality studies, the apparent benefit of collagen supplements on skin hydration, elasticity, and wrinkles was no longer statistically significant.4 The authors concluded that the current evidence base does not robustly support a definitive conclusion, and that high-quality, independently funded RCTs are needed.
This nuance is important context for anyone evaluating the collagen and skin evidence. The mechanistic rationale is plausible — supplemental collagen peptides may stimulate endogenous collagen synthesis in dermal fibroblasts, and the Pro-Hyp dipeptide has been shown in mechanistic research to influence fibroblast behaviour. Collagen peptides are also generally considered safe and well-tolerated at typical supplementation doses (5–15 g daily). But the clinical evidence, while promising, is not yet conclusive in the way established nutritional science would require for firm recommendations. A scientifically honest interpretation is that collagen peptides represent a plausible and low-risk addition to a skin health routine, with the most consistent evidence pointing to effects on hydration and elasticity after sustained use.
Supporting Nutrients: Biotin, Zinc, and Their Roles
Collagen and vitamin C do not operate in isolation within connective tissue biology. Two additional nutrients carry EFSA-approved claims relevant to skin and hair maintenance: biotin and zinc.
Biotin (vitamin B7) contributes to maintenance of normal skin and hair — an EFSA-approved claim. Biotin functions as an essential cofactor for five carboxylase enzymes involved in fatty acid synthesis, gluconeogenesis, and amino acid catabolism. These metabolic functions are relevant to the health of rapidly dividing cells including those in skin and hair follicles. Biotin deficiency produces characteristic dermatological signs including skin rash, alopecia, and brittle nails. However, it is important to note that clinical research suggests true biotin deficiency is uncommon in individuals with balanced dietary intake, and the evidence for biotin supplementation improving hair or nail parameters in individuals without underlying deficiency is currently limited.7 The EFSA claim addresses the nutrient's role in supporting normal function when adequately supplied — not a therapeutic hair or skin benefit in isolation.
Zinc contributes to maintenance of normal skin and hair — also an EFSA-approved claim. Zinc is involved in multiple processes relevant to skin integrity: it supports keratin and collagen structural proteins, acts as a co-factor for antioxidant enzymes (superoxide dismutase), contributes to normal DNA synthesis, and plays a role in epithelial cell turnover. Zinc deficiency is associated with dermatitis, delayed wound healing, and hair loss. Mild zinc insufficiency is relatively common in older adults. A dermatology review examining evidence for zinc supplementation noted that while the evidence base for topical and oral zinc in certain dermatological conditions exists, large-scale independent RCTs evaluating supplementation in already-replete individuals are limited.8
These nutrients are best understood as foundational requirements for normal connective tissue and skin biology. Ensuring adequate intake — whether through diet or supplementation where dietary gaps exist — provides the substrate for the normal cellular processes involved in skin and connective tissue maintenance.
Dosing, Forms, and Practical Considerations
Collagen peptides are the most studied supplemental form, given their superior absorption profile compared to intact native collagen. Doses used in human RCTs for skin outcomes have typically ranged from 2.5 g to 15 g per day, with most trials using 5–10 g daily. For joint-focused trials, similar dose ranges apply. Duration appears to matter: most trials showing measurable effects on skin parameters used supplementation periods of 8 to 12 weeks or longer.
Sources of collagen for supplementation include bovine (Type I and III), marine/fish (Type I), and chicken cartilage (Type II). The type most studied for skin applications is bovine or marine Type I hydrolysate; Type II (including native, undenatured forms) is more commonly studied in the joint context. The choice of source may be relevant for individuals with specific dietary restrictions or preferences (e.g., those avoiding bovine products may prefer marine collagen).
Vitamin C has a straightforward supplementation profile. As a water-soluble vitamin, it is excreted when taken in excess of tissue saturation, with negligible toxicity risk at typical supplementation doses. Some formulations deliberately combine collagen peptides with vitamin C, reflecting the nutrient's role in collagen synthesis — though whether this combination produces meaningfully superior outcomes compared to individual supplementation has not been comprehensively studied in humans.
For biotin and zinc, typical dietary intakes in individuals eating varied diets are often sufficient to meet daily requirements. Supplementation may be considered where dietary intake is restricted or where specific risk factors suggest insufficiency. Zinc upper tolerable intake levels are established at 25 mg/day in the EU; excessive long-term zinc intake can interfere with copper absorption.
What to Look For in a Connective Tissue Support Supplement
Transparency and quality control are the most practically useful criteria when evaluating any collagen or multi-nutrient supplement. Key markers include:
Third-party Certificate of Analysis (COA): An independent laboratory report confirming that the product contains what the label states, and that it is free from heavy metal contamination and microbial hazards. Reputable supplement brands, including those working with laboratories such as Eurofins, make COA data available on request or publicly visible.
Ingredient clarity: Clearly listed collagen type, source, and molecular weight information where available. For multi-nutrient formulations, each ingredient should be listed with its specific form (e.g., zinc as zinc citrate vs zinc oxide) and the dose per serving.
EFSA-aligned claims only: Supplements making clear, approved claims — such as vitamin C contributing to normal collagen formation, or biotin contributing to maintenance of normal skin and hair — are operating within the established evidence framework. Supplements making claims that go beyond this (e.g., "reverses skin ageing" or "repairs joint damage") are making statements that exceed what the current regulatory and evidence framework supports.
Longevity Complete includes vitamin C, biotin, and zinc — three nutrients with EFSA-approved claims relevant to skin, hair, and collagen formation. The formulation is third-party tested, with Certificate of Analysis available, and verified doping-free by NZVT. For individuals considering collagen peptides specifically, these would typically be taken as a separate product at the doses used in clinical research.
Q&A: Collagen, Vitamin C, and Connective Tissue Health
What does vitamin C actually do for collagen?
Vitamin C is an essential cofactor for the enzymes prolyl hydroxylase and lysyl hydroxylase, which modify proline and lysine residues in newly made procollagen chains.1 These modifications are required for the procollagen chains to fold into the stable triple-helix structure that gives collagen its strength. Vitamin C also directly promotes collagen gene expression. Without adequate vitamin C, the process of collagen formation is impaired — which is why severe deficiency (scurvy) produces symptoms related to connective tissue failure.
Does taking collagen supplements actually work for joints?
Human clinical trials suggest a plausible signal. A 2024 meta-analysis of 11 RCTs involving 870 participants reported that oral collagen supplementation was associated with improved joint pain and function scores compared to placebo in adults with knee osteoarthritis.2 However, the trials showed moderate risk of bias and high heterogeneity. The evidence is promising but not conclusive, and collagen supplements should be considered a supportive nutritional measure rather than a primary joint management strategy.
How long does it take to see results from collagen supplementation?
The clinical trials showing consistent skin benefits — particularly for hydration and elasticity — generally used supplementation periods of 8 to 12 weeks or longer.3 Joint-focused trials similarly used durations of 12 weeks to 6 months. Collagen synthesis is a biological process that operates over weeks and months; short-term supplementation (under 4 weeks) is unlikely to produce measurable changes in tissue parameters.
What is the best dose of collagen peptides?
Most skin-focused RCTs have used 2.5 g to 10 g of hydrolysed collagen daily, while joint-focused trials have used 5 g to 15 g. There is no single universally agreed dose, and optimal dosing may vary by individual, age, and health status. Doses used in published trials represent the most practical reference point. No specific EFSA authorised dose exists for collagen peptides as a supplement, and upper safety limits have not been formally established — though the products have a good general safety record in trials.
Is there a difference between collagen types (Type I, II, III)?
Type I collagen is the most abundant in skin, tendons, and bone. Type II collagen is the predominant type in cartilage. Type III collagen is found alongside Type I in skin and blood vessels. From a supplementation standpoint, most skin-focused trials have used hydrolysed Type I or mixed Type I/III from bovine or marine sources. Joint-focused trials have used both hydrolysed Type II collagen and native (undenatured) Type II collagen. Each type has its own specific research context, and there is not yet strong evidence that one source is definitively superior for any outcome.
Can I get enough vitamin C from diet alone for collagen support?
For most people with a varied diet including fruits and vegetables, dietary vitamin C intake is sufficient to support normal collagen synthesis. Foods particularly rich in vitamin C include citrus fruits, kiwi, bell peppers, broccoli, and strawberries. Supplementation may be relevant for individuals with limited dietary variety, smokers (who have increased vitamin C utilisation), or older adults with restricted diets. The EFSA-approved claim for vitamin C and collagen formation applies at adequate intake levels — not above-average supplemental doses.
Does biotin really help skin and hair?
Biotin contributes to maintenance of normal skin and hair — this is an EFSA-approved claim. However, this refers to biotin's role in supporting normal function when adequately supplied. Clinical research indicates that significant hair or nail benefits from biotin supplementation in individuals without underlying deficiency have not been consistently demonstrated in high-quality trials.7 Biotin is nonetheless an important B vitamin with well-established roles in metabolism, and ensuring adequate daily intake is a sound nutritional practice.
Is collagen supplementation safe?
Hydrolysed collagen peptides have a well-established safety record. No serious adverse effects have been reported in published clinical trials at typical supplementation doses. Collagen supplements are produced from animal sources (bovine, marine, porcine, or chicken), so individuals with specific dietary restrictions should select sources accordingly. Quality control through third-party testing is important for verifying product purity and freedom from contaminants.
What is collagen and why is it important for longevity?
Collagen is the most abundant protein in the body, providing structural support to skin, joints, tendons, and bone. It is classified as a family of over 28 proteins, with Types I, II, and III being most prevalent. Collagen production naturally declines with age, and supporting the biological processes involved in collagen synthesis — particularly through adequate vitamin C intake — is a foundation of connective tissue health across the lifespan.1
What is the EFSA claim for vitamin C and collagen?
The European Food Safety Authority has approved the claim that vitamin C contributes to normal collagen formation for the normal function of bones, cartilage, skin, and gums. This claim is based on the well-established role of vitamin C as an essential cofactor for the enzymes required to synthesise structurally functional collagen. It is one of the most robustly supported nutrient-function relationships in nutritional science.
What does the research say about collagen supplements for skin?
A 2023 meta-analysis of 26 RCTs involving 1,721 participants reported significantly improved skin hydration and elasticity in the collagen supplementation groups compared to placebo.3 However, a more recent 2025 meta-analysis found that when controlling for industry funding and study quality, the benefits were less clear.4 The evidence is promising but should be interpreted with appropriate caution while awaiting higher-quality independent trials.
What nutrients support joint health as part of a longevity routine?
For joint-related connective tissue, the most studied nutrients include collagen peptides (Type I and II hydrolysates have both been examined in RCTs), vitamin C (which contributes to normal collagen formation for cartilage), and vitamin D, calcium, magnesium, and zinc — all of which contribute to maintenance of normal bones. A whole-diet approach alongside regular movement forms the foundation, with supplementation considered where dietary gaps exist.
Do biotin and zinc support skin and hair health?
Both biotin and zinc carry EFSA-approved claims for contributing to maintenance of normal skin and hair. These claims reflect each nutrient's established role in normal cellular function — biotin as a metabolic cofactor and zinc as a trace mineral involved in protein synthesis, DNA synthesis, and antioxidant defence.8 Their role is best understood as providing the nutritional foundation for normal skin and hair biology, particularly where dietary intake may be insufficient.
How should I take collagen supplements for best results?
Based on the clinical trial literature, most studies showing measurable skin benefits used 5–10 g of hydrolysed collagen daily for 8–12 weeks or longer. Collagen peptide powders are typically dissolved in liquid and can be taken at any time of day. Some research has combined collagen with vitamin C to support collagen synthesis pathways, though the additive benefit of this combination versus collagen alone has not been definitively established in human trials. Consistency over weeks and months appears more important than timing of daily intake.
References
- Murad S, Grove D, Lindberg KA, Reynolds G, Sivarajah A, Pinnell SR. Regulation of collagen synthesis by ascorbic acid. Proc Natl Acad Sci U S A. 1981;78(5):2879–2882. View on PubMed ↗
- Simental-Mendía M, Ortega-Mata D, Acosta-Olivo CA, Simental-Mendía LE, Peña-Martínez VM, Vilchez-Cavazos F. Effect of collagen supplementation on knee osteoarthritis: an updated systematic review and meta-analysis of randomised controlled trials. Clin Exp Rheumatol. 2025;43(1):126–134. View on PubMed ↗
- Pu SY, Huang YL, Pu CM, Kang YN, Hoang KD, Chen KH, Chen C. Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis. Nutrients. 2023;15(9):2080. View on PubMed ↗
- Myung SK, et al. Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Med. 2025;138(9):1264–1277. View on PubMed ↗
- Pinnel SR, Murad S, Darr D. Induction of collagen synthesis by ascorbic acid: a possible mechanism. Arch Dermatol. 1987;123(12):1684–1686. View on PubMed ↗
- Zhu X, et al. Efficacy and safety of collagen derivatives for osteoarthritis: A trial sequential meta-analysis. Osteoarthritis Cartilage. 2024. View on PubMed ↗
- Patel DP, Swink SM, Castelo-Soccio L. A Review of the Use of Biotin for Hair Loss. Skin Appendage Disord. 2017;3(3):166–169. View on PubMed ↗
- Thompson KG, Kim N. Dietary supplements in dermatology: A review of the evidence for zinc, biotin, vitamin D, nicotinamide, and Polypodium. J Am Acad Dermatol. 2021;84(4):1042–1050. View on PubMed ↗
